Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01801358 |
| Title | A Phase Ib/II Study of AEB071 and MEK162 in Adult Patients With Metastatic Uveal Melanoma |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Novartis|Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | NLD | GBR | FRA | ESP | DEU |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Dana Farber Cancer Institute Dept. Onc | Boston | Massachusetts | 02215 | United States | Details | |
| Memorial Sloan Kettering Cancer Center Dept of Onc.. | New York | New York | 90033 | United States | Details | |
| Pfizer Investigative Site | Paris | 75231 | France | Details | ||
| Pfizer Investigative Site | Essen | 45147 | Germany | Details | ||
| Pfizer Investigative Site | Leiden | 2300 RC | Netherlands | Details | ||
| Pfizer Investigative Site | Madrid | 28050 | Spain | Details | ||
| Pfizer Investigative Site | London | SW3 6JJ | United Kingdom | Details |